CS logo
small CS logo
Dolnoslaskie Centrum Onkologii

Wroclaw, Poland
Hospital in Wrocław
plac Hirszfelda 12, 53-413 Wrocław

About Dolnoslaskie Centrum Onkologii


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Janssen Research & Development, LLC
3
Ipsen
2
Merck Sharp & Dohme LLC
2
Blueprint Medicines Corporation
1
Central European Cooperative Oncology Group
1
Eli Lilly and Company
1
Genmab
1
OSI Pharmaceuticals
1
Pierre Fabre Medicament
1
Total Rows: 10

Clinical Trials at Dolnoslaskie Centrum Onkologii


During the past decade, Dolnoslaskie Centrum Onkologii conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years444422332211001111332200Started TrialsCompleted Trails2017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
2001-11-29
2004-01-15
Completed
569
Zalutumumab in Patients With Non-curable Head and Neck Cancer
2006-11-01
2011-08-01
Completed
286
2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
2008-04-01
2014-12-01
Completed
564
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
2012-09-24
2018-07-13
Completed
498
A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma
2017-01-13
2023-07-26
Active, not recruiting
514
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
2017-06-30
2023-12-31
Active, not recruiting
1,101
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
2017-07-12
2029-06-24
Active, not recruiting
5,637
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
2017-12-11
2021-02-19
Terminated
446

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Dolnoslaskie Centrum Onkologii" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Ipsen" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Blueprint Medicines Corporation" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Dolnoslaskie Centrum Onkologii" #1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 7Hoffmann-La Roche: 7Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Ipsen: 2Ipsen: 2Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2Blueprint MedicinesCorporation: 1Blueprint MedicinesCorporation: 1Central EuropeanCooperative OncologyGroup: 1Central EuropeanCooperative OncologyGroup: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Genmab: 1Genmab: 1OSI Pharmaceuticals: 1OSI Pharmaceuticals: 1Pierre Fabre Medicament: 1Pierre Fabre Medicament: 1

Created with Highcharts 11.1.0Top CollaboratorsCanadian Cancer Trials Group: 1Canadian Cancer Trials Group: 1Chugai: 1Chugai: 1Eisai Inc.: 1Eisai Inc.: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Exelixis: 1Exelixis: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1

Clinical Trials Conditions at Dolnoslaskie Centrum Onkologii


According to Clinical.Site data, the most researched conditions in "Dolnoslaskie Centrum Onkologii" are "Melanoma" (3 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Advanced/Metastatic Gastroesophageal Adenocarcinoma" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Dolnoslaskie Centrum Onkologii" in a lesser frequency.

Clinical Trials Intervention Types at Dolnoslaskie Centrum Onkologii


Most popular intervention types in "Dolnoslaskie Centrum Onkologii" are "Drug" (17 trials), "Biological" (3 trials), "Other" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (4 trials), "Pembrolizumab" (3 trials), "5-FU" (2 trials) and "Capecitabine" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Dolnoslaskie Centrum Onkologii


The vast majority of trials in "Dolnoslaskie Centrum Onkologii" are 18 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Dolnoslaskie Centrum Onkologii


Currently, there are NaN active trials in "Dolnoslaskie Centrum Onkologii". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Dolnoslaskie Centrum Onkologii, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Dolnoslaskie Centrum Onkologii, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 17Phase 3: 17Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 8Active, not recruiting: 8Completed: 6Completed: 6Recruiting: 4Recruiting: 4Terminated: 1Terminated: 1Withdrawn: 1Withdrawn: 1

Departments of Dolnoslaskie Centrum Onkologii


Dolnoslaskie Centrum Onkologii has several departments that took part in Clinical trials: "Dolnoslaskie Centrum Transplantacji Komorkowych z Krajowym Bankiem Dawcow Szpiku" - 12 trials, "Dolnośląskie Centrum Onkologii; Oddział Onkologii Klinicznej i Chemioterapii" - 6 trials, "Lower-Silesian Oncology Centre" - 2 trials